ReNerve Limited (RNV) is an Australian biotechnology company that has altered peripheral nerve surgery with its ready-to-use solutions for peripheral nerve injuries (PNI).
Find out what a historical investment in ReNerve would be worth today using our RNV stock calculator.
Buying RNV shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in ReNerve in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in RNV
What is the ticker symbol of ReNerve?
The ticker symbol for ReNerve is RNV.
How much is one share of RNV?
One share of RNV is valued at $0.07 as of 20 November 2026.
What is the market capitalisation of ReNerve RNV?
As of 20 November 2026 ReNerve has a market cap of $9.83M.
What is the P/E ratio of RNV?
The Price to Earnings ratio of RNV is -2.00.
What is the Earnings Per Share of RNV?
The Earnings Per Share of RNV is -$0.04.
What is the 52-week high for ReNerve stock?
The ReNerve 52-week high stock price is $0.13.
What is the 52-week low for ReNerve stock?
The ReNerve 52-week low stock price is $0.07.
Can I buy RNV shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RNV shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.